Skip Navigation

European Heart Journal 2004 25(1):88-95; doi:10.1016/j.ehj.2003.10.022
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brunner, M.
Right arrow Articles by Zehender, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunner, M.
Right arrow Articles by Zehender, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

Long-term survival after pacemaker implantation

Prognostic importance of gender and baseline patient characteristics

Michael Brunnera,*, Manfred Olschewskib, Annette Geibela, Christoph Bodea and Manfred Zehendera

a Innere Medizin III-Kardiologie und Angiologie, Universitätsklinik Freiburg, Freiburg, Germany
b Institut für medizinische Biometrie und Informatik der Universitätsklinik Freiburg, Freiburg, Germany

* Correspondence to: Dr Michael Brunner, Universitätsklinik Freiburg, Innere Medizin III-Kardiologie und Angiologie, Hugstetterstr. 55, D-79106 Freiburg, Germany. Tel: +49-761-270-3401, Fax: +49-761-270-3799
E-mail address: brunner{at}medizin.ukl.uni-freiburg.de

Received 27 June 2003; revised 1 October 2003; accepted 16 October 2003

Abstract

Permanent cardiac pacing is the treatment of choice in severe and symptomatic bradycardia. To determine factors associated with longer survival we analysed the survival times and baseline characteristics of 6505 patients after pacemaker implantation. This longitudinal study with 30 years of follow-up was performed in a single centre university hospital with all-cause mortality as the end-point.

In 6505 patients we analysed a total of 30 948 years of patient follow-up, median survival was 101.9 months (~8.5 years), with 44.8% of patients alive after 10 years and 21.4% alive after 20 years. In all subgroups women had a significantly longer survival than men (118 vs 91.7 months, P<0.0001), despite a markedly higher age at implantation (73.2 years vs 71 years, P<0.0001). Survival of patients with sick-sinus-syndrome was significantly better than in patients with high degree AV-block, which in turn, was better than survival of patients with atrial fibrillation (132.9 months vs 94.2 months vs 85.1 months, P<0.0001). Multivariate analysis revealed several independent factors: age, gender, decade of implantation, type of pacemaker, index arrhythmia and initial symptoms. Interestingly, if only the patients of the last decade were analysed multivariately, neither pacing mode nor index arrhythmia wereindependently associated with survival.

In conclusion, survival of patients with pacemakers is independently influenced by several baseline characteristics which can identify patients with very long survival.

Key Words: Artificial pacemaker • Long-term survival • Gender


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
S. Asbach, M. Olschewski, T. S. Faber, M. Zehender, C. Bode, and M. Brunner
Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients
Europace, April 1, 2008; 10(4): 391 - 394.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. de Teresa, J. J. Gomez-Doblas, G. Lamas, J. Alzueta, I. Fernandez-Lozano, E. Cobo, X. Navarro, F. Navarro-Lopez, and M. Stockburger
Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: rationale and design of the PREVENT-HF study
Europace, June 1, 2007; 9(6): 442 - 446.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. C. Funck, J.-J. Blanc, H.-H. Mueller, C. Schade-Brittinger, C. Bailleul, B. Maisch, and for the BioPace Study Group
Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study.
Europace, August 1, 2006; 8(8): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Boriani, L. Rusconi, M. Biffi, L. Pavia, M. Sassara, D. Malfitano, M. G. Bongiorni, L. Padeletti, I. Filice, D. Sanfelici, et al.
Role of ventricular autocapture function in increasing longevity of DDDR pacemakers: a prospective study.
Europace, March 1, 2006; 8(3): 216 - 220.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.